IBDEI188 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21727,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,21727,1,5,0)
 ;;=5^Chr Airway Obstruction NEC
 ;;^UTILITY(U,$J,358.3,21727,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,21728,0)
 ;;=530.81^^118^1346^20
 ;;^UTILITY(U,$J,358.3,21728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21728,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,21728,1,5,0)
 ;;=5^Esophageal Reflux
 ;;^UTILITY(U,$J,358.3,21728,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,21729,0)
 ;;=250.02^^118^1346^16
 ;;^UTILITY(U,$J,358.3,21729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21729,1,4,0)
 ;;=4^250.02
 ;;^UTILITY(U,$J,358.3,21729,1,5,0)
 ;;=5^DM Type 2 w/o Complications,Uncntrld
 ;;^UTILITY(U,$J,358.3,21729,2)
 ;;=^331781
 ;;^UTILITY(U,$J,358.3,21730,0)
 ;;=250.03^^118^1346^12
 ;;^UTILITY(U,$J,358.3,21730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21730,1,4,0)
 ;;=4^250.03
 ;;^UTILITY(U,$J,358.3,21730,1,5,0)
 ;;=5^DM Type 1 w/o Complications,Uncntrld
 ;;^UTILITY(U,$J,358.3,21730,2)
 ;;=^331782
 ;;^UTILITY(U,$J,358.3,21731,0)
 ;;=250.71^^118^1346^10
 ;;^UTILITY(U,$J,358.3,21731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21731,1,4,0)
 ;;=4^250.71
 ;;^UTILITY(U,$J,358.3,21731,1,5,0)
 ;;=5^DM Type 1 w/ Circ Complications
 ;;^UTILITY(U,$J,358.3,21731,2)
 ;;=^331808
 ;;^UTILITY(U,$J,358.3,21732,0)
 ;;=250.70^^118^1346^14
 ;;^UTILITY(U,$J,358.3,21732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21732,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,21732,1,5,0)
 ;;=5^DM Type 2 w/ Circ Complications
 ;;^UTILITY(U,$J,358.3,21732,2)
 ;;=^331807
 ;;^UTILITY(U,$J,358.3,21733,0)
 ;;=250.72^^118^1346^15
 ;;^UTILITY(U,$J,358.3,21733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21733,1,4,0)
 ;;=4^250.72
 ;;^UTILITY(U,$J,358.3,21733,1,5,0)
 ;;=5^DM Type 2 w/ Circ Complications,Uncntrld
 ;;^UTILITY(U,$J,358.3,21733,2)
 ;;=^331809
 ;;^UTILITY(U,$J,358.3,21734,0)
 ;;=250.73^^118^1346^11
 ;;^UTILITY(U,$J,358.3,21734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21734,1,4,0)
 ;;=4^250.73
 ;;^UTILITY(U,$J,358.3,21734,1,5,0)
 ;;=5^DM Type 1 w/ Circ Complications,Uncntrld
 ;;^UTILITY(U,$J,358.3,21734,2)
 ;;=^331810
 ;;^UTILITY(U,$J,358.3,21735,0)
 ;;=511.9^^118^1346^29
 ;;^UTILITY(U,$J,358.3,21735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21735,1,4,0)
 ;;=4^511.9
 ;;^UTILITY(U,$J,358.3,21735,1,5,0)
 ;;=5^Pleural Effusion
 ;;^UTILITY(U,$J,358.3,21735,2)
 ;;=^123973
 ;;^UTILITY(U,$J,358.3,21736,0)
 ;;=272.0^^118^1347^4
 ;;^UTILITY(U,$J,358.3,21736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21736,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,21736,1,5,0)
 ;;=5^Hypocholesterolem Pure
 ;;^UTILITY(U,$J,358.3,21736,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,21737,0)
 ;;=272.1^^118^1347^1
 ;;^UTILITY(U,$J,358.3,21737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21737,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,21737,1,5,0)
 ;;=5^Hyperglyceridemia Pure
 ;;^UTILITY(U,$J,358.3,21737,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,21738,0)
 ;;=272.2^^118^1347^2
 ;;^UTILITY(U,$J,358.3,21738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21738,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,21738,1,5,0)
 ;;=5^Hyperlipidemia Mixed
 ;;^UTILITY(U,$J,358.3,21738,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,21739,0)
 ;;=272.4^^118^1347^3
 ;;^UTILITY(U,$J,358.3,21739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21739,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,21739,1,5,0)
 ;;=5^Hyperlipidemia Other
 ;;^UTILITY(U,$J,358.3,21739,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,21740,0)
 ;;=272.5^^118^1347^5
 ;;^UTILITY(U,$J,358.3,21740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21740,1,4,0)
 ;;=4^272.5
 ;;
 ;;$END ROU IBDEI188
